Author:
Li Hong-Yu,Li Bo,Wei Yong-Gang,Yan Lv-Nan,Wen Tian-Fu,Zhao Ji-Chun,Xu Ming-Qing,Wang Wen-Tao,Ma Yu-Kui,Yang Jia-Yin
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Physiology
Reference15 articles.
1. Manzarbeitia C, Reich DJ, Rothstein KD, Braitman LE, Levin S, Munoz SJ. Tacrolimus conversion improves hyperlipidemic states in stable liver transplant recipients. Liver Transpl. 2001;7:93–99.
2. Canzanello VJ, Schwartz L, Taler SJ, et al. Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506). Liver Transpl Surg. 1997;3:1–9.
3. Smith SL. Risk factors for premature coronary heart disease after successful liver transplantation in adults. J Transpl Coord. 1996;6:178–185.
4. Stegall MD, Everson G, Schroter G, Bilir B, Karrer F, Kam I. Metabolic complications after liver transplantation. Diabetes, hypercholesterolemia, hypertension, and obesity. Transplantation. 1995;60(9):1057–1060.
5. Tisone G, Angelico M, Palmieri G, et al. A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation. Transplantation. 1999;67:1308–1313.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献